Cutler Group’s Kite Pharma, Inc. KITE Stock Holding History

Cutler Group’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-4,684	Closed	-$842K	–	6648
2017 Q3	$842K	Sell	4,684 -4,665	-50%	-$650K	0.03%	410
2017 Q2	$969K	Buy	9,349 +86	+0.9%	+$7.02K	0.04%	426
2017 Q1	$727K	Buy	9,263 +7,497	+425%	+$464K	0.03%	503
2016 Q4	$79K	Sell	1,766 -11,412	-87%	-$560K	﹤0.01%	2122
2016 Q3	$736K	Buy	13,178 +4,300	+48%	+$240K	0.03%	441
2016 Q2	$443K	Buy	8,878 +3,300	+59%	+$162K	0.02%	653
2016 Q1	$256K	Sell	5,578 -6,101	-52%	-$296K	0.02%	868
2015 Q4	$719K	Buy	+11,679	New	+$822K	0.04%	456

Cutler Group's KITE Position: Q4 2017 in Review

Cutler Group sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 4,684 shares — an estimated $842K sold.

Cutler Group first reported a position in KITE in Q4 2015 and held it in 8 quarters. The position peaked at $969K in Q2 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Cutler Group reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Cutler Group sold 4,684 Kite Pharma, Inc. shares in Q4 2017, an estimated $842K.
Cutler Group first reported a position in Kite Pharma, Inc. in Q4 2015 and held it in 8 quarters.
Cutler Group's Kite Pharma, Inc. position peaked at $969K in Q2 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Cutler Group's 13F filing for Q4 2017, filed 17 Jan 2018.